This Ascendis Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursdaybenzinga_article·Aug 27 at 02:52 PMASND-0.21%ODTX+8.94%
Odyssey Therapeutics management to join Morgan Stanley Global Healthcare Conference fireside chatPUBT·Aug 26 at 12:06 PMMS+0.26%ODTX+8.94%
Odyssey Therapeutics (ODTX) Stock Looks Reasonable As AI Research News LandsSimplywall·Aug 9 at 07:30 PMODTX+8.94%EVO-2.11%
Odyssey Therapeutics (NASDAQ:ODTX) Given New $29.00 Price Target at JPMorgan Chase & Co.Market Beat·Aug 7 at 04:42 PMODTX+8.94%
Evotec and Odyssey collaborate on AI-enabled R&DPharmaceutical Technology·Aug 7 at 09:10 AMODTX+8.94%EVO-2.11%
Biotech Stocks At 52-Week Highs - BVS, TVTX, ODTX, CRL Climb With Q2 Results, ACRSrttnews·Aug 6 at 08:55 AMACRS+3.70%CRL-1.65%
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases | EVO Stock NewsStockTitan·Aug 5 at 10:16 PMODTX+8.94%EVO-2.11%
Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate UpdateUnusual Whales·Aug 4 at 11:02 AMODTX+8.94%
Odyssey posts June 2026 corporate presentation highlighting OD-001 Phase 2a results and $464M pro forma cashTradingView·Jun 23 at 12:53 PMODTX+8.94%
